Table 1

Patient characteristics

No. of patients
Total11
 Treated with 72-h flavopiridol5
 Treated with 1-h flavopiridol6
Median age, y (range)55 (33–71)
Median ECOG performance status1
Hormone receptor status
 ER+ or PR+3
 ER− and PR−7
HER2/neu-positive5
Previous paclitaxel
 Adjuvant5
 Neoadjuvant1
 Metastatic6
Prior high-dose chemotherapy2
Median no. of prior hormonal therapies (range)1 (0–2)
Median no. of prior chemotherapy regimens (range)1 (0–3)
  • Abbreviations: ECOG, Eastern Cooperative Oncology Group; ER, estrogen receptor; PR, progesterone receptor.